PEROTTI, Paola Carla Giuseppina
PEROTTI, Paola Carla Giuseppina
SCIENZE CLINICHE E BIOLOGICHE
18F-FDG PET/CT in the post-operative monitoring of patients with adrenocortical carcinoma.
2015-01-01 Ardito, A; Massaglia, C; Pelosi, E; Zaggia, B; Basile, V; Brambilla, R; Vigna-Taglianti, F; Duregon, E; Arena, V; Perotti, P; Penna, D; Terzolo, M.
A current perspective on treatment of adrenocortical carcinoma
2014-01-01 Massimo Terzolo, Silvia De Francia, Arianna Ardito, Paola Perotti, Laura Ferrari, Alfredo Berruti
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients
2019-01-01 Cosentini, Deborah; Badalamenti, Giuseppe; Grisanti, Salvatore; Basile, Vittoria; Rapa, Ida; Cerri, Sara; Spallanzani, Andrea; Perotti, Paola; Musso, Emanuela; Laganà, Marta; Ferrari, Vittorio; Luppi, Gabriele; Dalla Volta, Alberto; Incorvaia, Lorena; Sigala, Sandra; Russo, Antonio; Volante, Marco; Terzolo, Massimo; Berruti, Alfredo
Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma.
2018-01-01 Claps, Melanie; Cerri, Sara; Grisanti, Salvatore; Lazzari, Barbara; Ferrari, Vittorio; Roca, Elisa; Perotti, Paola; Terzolo, Massimo; Sigala, Sandra; Berruti, Alfredo
Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence.
2019-01-01 Calabrese A, Basile V, Puglisi S, Perotti P, Pia A, Saba L, Berchialla P, Porpiglia F, Veltri A, Volante M, Reimondo G, Berruti A, Terzolo M.
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study
2023-01-01 Massimo Terzolo; Martin Fassnacht; Paola Perotti; Rossella Libé; Darko Kastelan; André Lacroix; Wiebke Arlt; Harm Reinout Haak; Paola Loli; Bénédicte Decoudier; Helene Lasolle; Marcus Quinkler; Magalie Haissaguerre; Olivier Chabre; Philippe Caron; Antonio Stigliano; Roberta Giordano; Maria Chiara Zatelli; Irina Bancos; Maria Candida Barisson Villares Fragoso; Letizia Canu; Michaela Luconi; Soraya Puglisi; Vittoria Basile; Giuseppe Reimondo; Matthias Kroiss; Felix Megerle; Stefanie Hahner; Otilia Kimpel; Tina Dusek; Svenja Nölting; Isabelle Bourdeau; Vasileios Chortis; Madeleine Hester Ettaieb; Deborah Cosentini; Salvatore Grisanti; Eric Baudin; Paola Berchialla; Francesca Bovis; Maria Pia Sormani; Paolo Bruzzi; Felix Beuschlein; Jerome Bertherat; Alfredo Berruti.
Adrenal cortical carcinoma: mitotane and beyond
2018-01-01 Silvia De Francia, Paola Perotti, Vittoria Basile, Antonina Germano, Massimo Terzolo
Adrenocortical Carcinoma with Hypercortisolism.
2018-01-01 Puglisi S, Perotti P, Pia A, Reimondo G, Terzolo M.
Aluminium blunts the proliferative response and increases apoptosis of cultured human cells: putative relationship to alzheimer's disease
2007-01-01 PROLO P; CHIAPPELLI F; GRASSO E; ROSSO MG; NEAGOS N; DOVIO A; SARTORI ML; PEROTTI P; FANTÒ F; CIVITA M; FIORUCCI A; VILLANUEVA P; ANGELI A
Analysis of BCLI, N363S and ER22/23EK polymorphisms of the glucocorticoid receptor gene in adrenal incidentalomas
2016-01-01 Reimondo, Giuseppe; Chiodini, Iacopo; Puglisi, Soraya; Pia, Anna; Morelli, Valentina; Kastelan, Darko; Cannavo, Salvatore; Berchialla, Paola; Giachino, Daniela; Perotti, Paola; Cuccurullo, Alessandra; Paccotti, Piero; Beck-Peccoz, Paolo; Marchi, Mario De; Terzolo, Massimo
Changes in body composition after androgen deprivation therapy (ADT) in prostate cancer patients. Relationship with disease outcome
2008-01-01 A. Berruti; F. Vana; M. Tucci; A. Mosca; L. Russo; G. Gorzegno; A. Saini; P. Perotti; M. Tampellini; L. Dogliotti
Chemotherapy
2011-01-01 Alfredo Berruti; Paola Sperone; Paola Perotti; Anna Ferrero; Luigi Dogliotti; and Massimo Terzolo
CYP11B1 has no role in mitotane action and metabolism in adrenocortical carcinoma cells
2018-01-01 Germano, Antonina; Saba, Laura; De Francia, Silvia; Rapa, Ida; Perotti, Paola; Berruti, Alfredo; Volante, Marco; Terzolo, Massimo*
Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options.
2018-01-01 Puglisi S, Perotti P, Cosentini D, Roca E, Basile V, Berruti A, Terzolo M.
Determination of salivary cortisol to assess time related changes of the adrenal response to stress in critically ill patients
2019-01-01 Puglisi S, Pizzuto A, Laface B, Panero F, Aprà F, Palmas E, Perotti P, Reimondo G, Boccuzzi A, Terzolo M
Differential expression of determinants of glucocorticoid sensitivity in androgen-dependent and androgen-independent human prostate cancer cell lines
2009-01-01 Dovio A; Sartori ML; De Francia S; Mussino S; Perotti P; Saba L; Abbadessa G; Racca S; Angeli A.
Differential patterns of glucocorticoid receptors and 11beta hydroxysteroid dehydrogenase activity in androgen-dependent and androgen-independent prostate cancer cell lines. Relevance to glucocorticoid sensitivity.
2007-01-01 Dovio A; Sartori ML; Perotti P; Abbadessa G; De Francia S; Bianco E; Racca S; Angeli A.
Effects of mitotane on the hypothalamic-pituitary-adrenal axis in patients with adrenocortical carcinoma
2017-01-01 Reimondo, Giuseppe Matteo; Puglisi, Soraya; Zaggia, Barbara; Basile, Vittoria; Saba, Laura; Perotti, Paola Carla Giuseppina; DE FRANCIA, Silvia; Volante, Marco; Maria Chiara Zatelli, ; Salvatore, Cannavò; Terzolo, Massimo
Efficacy of repeat surgery in patients with recurrent adrenocortical cancer (ACC)
2009-01-01 DAFFARA Fulvia Claudia, ; DE FRANCIA SILVIA, ; Ardito, Arianna; Zaggia, Barbara; Fiori, C.; Angeli, Alberto; SCARPA Roberto Mario, ; Porpiglia, Francesco; Perotti, P.; Berruti, Alfredo; Terzolo, Massimo
Gemcitabine-based chemotherapy in adrenocortical carcinoma: A multicenter study of efficacy and predictive factors
2017-01-01 Henning J.E.K.; Deutschbein T.; Altieri B.; Steinhauer S.; Kircher S.; Sbiera S.; Wild V.; Schlotelburg W.; Kroiss M.; Perotti P.; Rosenwald A.; Berruti A.; Fassnacht M.; Ronchi C.L.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 18F-FDG PET/CT in the post-operative monitoring of patients with adrenocortical carcinoma. | 2015 | Ardito, A; Massaglia, C; Pelosi, E; Zaggia, B; Basile, V; Brambilla, R; Vigna-Taglianti, F; Duregon, E; Arena, V; Perotti, P; Penna, D; Terzolo, M. | |
| A current perspective on treatment of adrenocortical carcinoma | 2014 | Massimo Terzolo, Silvia De Francia, Arianna Ardito, Paola Perotti, Laura Ferrari, Alfredo Berruti | |
| Activity and safety of temozolomide in advanced adrenocortical carcinoma patients | 2019 | Cosentini, Deborah; Badalamenti, Giuseppe; Grisanti, Salvatore; Basile, Vittoria; Rapa, Ida; Cerri, Sara; Spallanzani, Andrea; Perotti, Paola; Musso, Emanuela; Laganà, Marta; Ferrari, Vittorio; Luppi, Gabriele; Dalla Volta, Alberto; Incorvaia, Lorena; Sigala, Sandra; Russo, Antonio; Volante, Marco; Terzolo, Massimo; Berruti, Alfredo | |
| Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma. | 2018 | Claps, Melanie; Cerri, Sara; Grisanti, Salvatore; Lazzari, Barbara; Ferrari, Vittorio; Roca, Elisa; Perotti, Paola; Terzolo, Massimo; Sigala, Sandra; Berruti, Alfredo | |
| Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence. | 2019 | Calabrese A, Basile V, Puglisi S, Perotti P, Pia A, Saba L, Berchialla P, Porpiglia F, Veltri A, Volante M, Reimondo G, Berruti A, Terzolo M. | |
| Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study | 2023 | Massimo Terzolo; Martin Fassnacht; Paola Perotti; Rossella Libé; Darko Kastelan; André Lacroix; Wiebke Arlt; Harm Reinout Haak; Paola Loli; Bénédicte Decoudier; Helene Lasolle; Marcus Quinkler; Magalie Haissaguerre; Olivier Chabre; Philippe Caron; Antonio Stigliano; Roberta Giordano; Maria Chiara Zatelli; Irina Bancos; Maria Candida Barisson Villares Fragoso; Letizia Canu; Michaela Luconi; Soraya Puglisi; Vittoria Basile; Giuseppe Reimondo; Matthias Kroiss; Felix Megerle; Stefanie Hahner; Otilia Kimpel; Tina Dusek; Svenja Nölting; Isabelle Bourdeau; Vasileios Chortis; Madeleine Hester Ettaieb; Deborah Cosentini; Salvatore Grisanti; Eric Baudin; Paola Berchialla; Francesca Bovis; Maria Pia Sormani; Paolo Bruzzi; Felix Beuschlein; Jerome Bertherat; Alfredo Berruti. | |
| Adrenal cortical carcinoma: mitotane and beyond | 2018 | Silvia De Francia, Paola Perotti, Vittoria Basile, Antonina Germano, Massimo Terzolo | |
| Adrenocortical Carcinoma with Hypercortisolism. | 2018 | Puglisi S, Perotti P, Pia A, Reimondo G, Terzolo M. | |
| Aluminium blunts the proliferative response and increases apoptosis of cultured human cells: putative relationship to alzheimer's disease | 2007 | PROLO P; CHIAPPELLI F; GRASSO E; ROSSO MG; NEAGOS N; DOVIO A; SARTORI ML; PEROTTI P; FANTÒ F; CIVITA M; FIORUCCI A; VILLANUEVA P; ANGELI A | |
| Analysis of BCLI, N363S and ER22/23EK polymorphisms of the glucocorticoid receptor gene in adrenal incidentalomas | 2016 | Reimondo, Giuseppe; Chiodini, Iacopo; Puglisi, Soraya; Pia, Anna; Morelli, Valentina; Kastelan, Darko; Cannavo, Salvatore; Berchialla, Paola; Giachino, Daniela; Perotti, Paola; Cuccurullo, Alessandra; Paccotti, Piero; Beck-Peccoz, Paolo; Marchi, Mario De; Terzolo, Massimo | |
| Changes in body composition after androgen deprivation therapy (ADT) in prostate cancer patients. Relationship with disease outcome | 2008 | A. Berruti; F. Vana; M. Tucci; A. Mosca; L. Russo; G. Gorzegno; A. Saini; P. Perotti; M. Tampellini; L. Dogliotti | |
| Chemotherapy | 2011 | Alfredo Berruti; Paola Sperone; Paola Perotti; Anna Ferrero; Luigi Dogliotti; and Massimo Terzolo | |
| CYP11B1 has no role in mitotane action and metabolism in adrenocortical carcinoma cells | 2018 | Germano, Antonina; Saba, Laura; De Francia, Silvia; Rapa, Ida; Perotti, Paola; Berruti, Alfredo; Volante, Marco; Terzolo, Massimo* | |
| Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options. | 2018 | Puglisi S, Perotti P, Cosentini D, Roca E, Basile V, Berruti A, Terzolo M. | |
| Determination of salivary cortisol to assess time related changes of the adrenal response to stress in critically ill patients | 2019 | Puglisi S, Pizzuto A, Laface B, Panero F, Aprà F, Palmas E, Perotti P, Reimondo G, Boccuzzi A, Terzolo M | |
| Differential expression of determinants of glucocorticoid sensitivity in androgen-dependent and androgen-independent human prostate cancer cell lines | 2009 | Dovio A; Sartori ML; De Francia S; Mussino S; Perotti P; Saba L; Abbadessa G; Racca S; Angeli A. | |
| Differential patterns of glucocorticoid receptors and 11beta hydroxysteroid dehydrogenase activity in androgen-dependent and androgen-independent prostate cancer cell lines. Relevance to glucocorticoid sensitivity. | 2007 | Dovio A; Sartori ML; Perotti P; Abbadessa G; De Francia S; Bianco E; Racca S; Angeli A. | |
| Effects of mitotane on the hypothalamic-pituitary-adrenal axis in patients with adrenocortical carcinoma | 2017 | Reimondo, Giuseppe Matteo; Puglisi, Soraya; Zaggia, Barbara; Basile, Vittoria; Saba, Laura; Perotti, Paola Carla Giuseppina; DE FRANCIA, Silvia; Volante, Marco; Maria Chiara Zatelli, ; Salvatore, Cannavò; Terzolo, Massimo | |
| Efficacy of repeat surgery in patients with recurrent adrenocortical cancer (ACC) | 2009 | DAFFARA Fulvia Claudia, ; DE FRANCIA SILVIA, ; Ardito, Arianna; Zaggia, Barbara; Fiori, C.; Angeli, Alberto; SCARPA Roberto Mario, ; Porpiglia, Francesco; Perotti, P.; Berruti, Alfredo; Terzolo, Massimo | |
| Gemcitabine-based chemotherapy in adrenocortical carcinoma: A multicenter study of efficacy and predictive factors | 2017 | Henning J.E.K.; Deutschbein T.; Altieri B.; Steinhauer S.; Kircher S.; Sbiera S.; Wild V.; Schlotelburg W.; Kroiss M.; Perotti P.; Rosenwald A.; Berruti A.; Fassnacht M.; Ronchi C.L. |